Identita

Upadacitinib Impurity 13

Neuvedeno · C27H33N5O5

01Identita

Lazychem IDLC-32763
CAS RNNeuvedeno
PubChem CID171935236
Molecular formulaC27H33N5O5
Molecular weight507.6 g/mol
IUPAC namebenzyl (3S,4R)-3-ethyl-4-[2-[(2-methylpropan-2-yl)oxycarbonyl-(5H-pyrrolo[2,3-b]pyrazin-2-yl)amino]acetyl]pyrrolidine-1-carboxylate
InChIKeyKDRLYHOFOQLJFV-UXHICEINSA-N

02Struktura a stereochemie

Two-dimensional chemical structure of Upadacitinib Impurity 13
Two-dimensional structure for the PubChem identity linked to this record. Confirm the identifiers before analytical use.

The parsed structure contains 4 rings, includes aromatic atoms, includes aliphatic carbon, has 2 defined stereocentres. These statements are calculated from the published structure string.

Defined stereocentres2
Ring count4
Secondary amines0
Tertiary amines0
SMILESCC[C@@H]1CN(C[C@@H]1C(=O)CN(C2=CN=C3C(=N2)C=CN3)C(=O)OC(C)(C)C)C(=O)OCC4=CC=CC=C4
InChINeuvedeno

03Stereochemistry

The published structure contains 2 defined and 0 unassigned tetrahedral stereocentres. The exact wedge and dash depiction is shown above.

Defined centres2Structure assigned
Unassigned centres0Structure unspecified
Assignment statusFully assignedExact published identity
Tetrahedral upper bound≤ 4Before symmetry reduction

Published same-connectivity configurations

1 record

These records have the same connectivity, molecular formula and protonation layer, but a different complete InChIKey stereochemical layer. Only separately structure-linked records are shown.

No additional structure-linked configuration with the same connectivity is currently present in the LazyChem dataset.

Scope: The mathematical 2^n value is only an upper bound. Symmetry and other stereogenic elements can change the number of distinct stereoisomers. A hypothetical configuration is not published as a compound record without a verified structure identity.

04Stav v Indii

Exact-compound status is evaluated only against the published name and CAS number. Confirm the current official instrument before a regulatory decision.

05Názvy a vztahy

API a mateřské léčivo

Neuvedeno

Názvy a vztahy

    06Zdroje